toujeo glp 1 GLP-1 use tripled among non-diabetics, reaching $5.8B in 2022 What Foods and Drinks Are

As the use of GLP-1 RA expands, ongoing monitoring of side effects, especially those that are underrecognized in clinical settings, is essential for a better understanding of patient experiences and guiding future studies

3 and 4

Malipatlolla, D

A 2025 randomized, double-blind, placebo-controlled trial published in Clinical Nutrition found that 15 mg/day of hydroxytyrosol improved antioxidant and anti-inflammatory status in overweight individuals with prediabetes over 16 weeks, while preserving insulin sensitivity (Moratilla-Rivera et al., 2025)

Sabet argued Costcos offer is a positive development, but we are in dire need of improved insurance coverage for these treatments, so that the patients who need them the most can access them. 4